Network to Network (N2) is happy to announce the release of the ICH E6 R2 updated Good Clinical Practice (GCP) Basic Course. Now available through the HHS’ Collaborative Institutional Training Initiative (CITI) platform.
This 10-module course discusses good clinical practice as it relates to clinical trials. The discussion is focused on the International Council for Harmonisation (ICH)-E6 (R2) guidelines and applicable regulations in Canada such as Health Canada-Division 5, and The Tri-Council Policy Statement 2.
N2 has worked with TransCelerate to assure that the high-quality CITI Canada GCP course accessible to N2 members meets their standards. This means if you are working with a TransCelerate affiliated company you can assure them that your CITI Canada training has formal approval and recognition from TransCelerate.
For more information please review the article “How to Determine if a GCP Course Meets TransCelerate BioPharma Minimum Criteria” which provides a brief overview of the TransCelerate certification.
WHO SHOULD TAKE THIS COURSE?
1. Persons proposing to conduct clinical trials primarily in Canada.
2. Those involved with TransCelerate BioPharma, which represents a number of biopharmaceutical companies
3. Anyone interested in furthering their clinical research education and skillset Start Your Training!